REGENXBIO (RGNX) News Today $7.46 -0.39 (-4.97%) Closing price 04:00 PM EasternExtended Trading$7.47 +0.01 (+0.13%) As of 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RGNX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period REGENXBIO (NASDAQ:RGNX) Stock Rating Lowered by Wall Street ZenAugust 11 at 3:51 AM | americanbankingnews.comREGENXBIO's (RGNX) "Buy" Rating Reiterated at Chardan CapitalAugust 11 at 2:24 AM | americanbankingnews.comREGENXBIO (NASDAQ:RGNX) Shares Pass Below 50-Day Moving Average Following Weak EarningsAugust 10 at 12:15 AM | marketbeat.comRoyal Bank Of Canada Cuts REGENXBIO (NASDAQ:RGNX) Price Target to $17.00August 10 at 3:09 PM | marketbeat.comREGENXBIO (NASDAQ:RGNX) Downgraded to "Strong Sell" Rating by Wall Street ZenAugust 10 at 3:33 AM | marketbeat.comREGENXBIO (NASDAQ:RGNX) Given New $17.00 Price Target at Royal Bank Of CanadaAugust 10 at 2:25 AM | americanbankingnews.comREGENXBIO (NASDAQ:RGNX) Stock Passes Below Fifty Day Moving Average After Earnings MissAugust 10 at 2:43 AM | americanbankingnews.comThese Analysts Just Made An Incredible Downgrade To Their REGENXBIO Inc. (NASDAQ:RGNX) EPS ForecastsAugust 9 at 5:16 PM | uk.finance.yahoo.comBarclays Cuts REGENXBIO (NASDAQ:RGNX) Price Target to $37.00August 9 at 11:18 AM | marketbeat.comREGENXBIO (NASDAQ:RGNX) Given Buy Rating at Chardan CapitalAugust 9 at 8:30 AM | marketbeat.comREGENXBIO Reports Second Quarter 2025 Financial Results and Operational HighlightsAugust 7, 2025 | prnewswire.comREGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic RetinopathyAugust 7, 2025 | prnewswire.comRegenxbio Q2 2025 Earnings PreviewAugust 7, 2025 | msn.comREGENXBIO Publishes Preclinical Data Highlighting RGX-202’s Potential for Duchenne Muscular DystrophyAugust 1, 2025 | insidermonkey.comGSA Capital Partners LLP Boosts Stake in REGENXBIO Inc. (NASDAQ:RGNX)August 1, 2025 | marketbeat.comREGENXBIO to Host Conference Call on August 7 to Discuss Second Quarter 2025 Financial Results and Operational HighlightsJuly 31, 2025 | prnewswire.comREGENXBIO (RGNX) Expected to Announce Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comCerity Partners LLC Makes New $228,000 Investment in REGENXBIO Inc. (NASDAQ:RGNX)July 29, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Receives Average Rating of "Moderate Buy" from BrokeragesJuly 25, 2025 | marketbeat.comREGENXBIO Inc. (RGNX): A Bull Case TheoryJuly 24, 2025 | insidermonkey.comFY2028 EPS Estimates for REGENXBIO Raised by Leerink PartnrsJuly 21, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) is largely controlled by institutional shareholders who own 67% of the companyJuly 18, 2025 | finance.yahoo.comREGENXBIO Announces Publication of Preclinical Results Demonstrating ...July 11, 2025 | morningstar.comMREGENXBIO Announces Publication of Preclinical Results Demonstrating Functional Benefits of Novel Microdystrophin Construct in RGX-202 Investigational Gene Therapy for Duchenne Muscular DystrophyJuly 10, 2025 | prnewswire.comRGNX | REGENXBIO Inc. Annual Income Statement - MarketWatchJuly 6, 2025 | marketwatch.comJanney Montgomery Scott LLC Makes New Investment in REGENXBIO Inc. (NASDAQ:RGNX)July 4, 2025 | marketbeat.comAssenagon Asset Management S.A. Sells 283,399 Shares of REGENXBIO Inc. (NASDAQ:RGNX)June 16, 2025 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Stock Price Up 6.1% - What's Next?June 11, 2025 | marketbeat.comA Glimpse Into The Expert Outlook On Regenxbio Through 8 AnalystsJune 9, 2025 | benzinga.comREGENXBIO's (RGNX) Buy Rating Reaffirmed at Chardan CapitalJune 9, 2025 | marketbeat.comRegenxbio's RGX-121 Could Become The New Standard Of Care In Hunter SyndromeJune 6, 2025 | seekingalpha.comREGENXBIO updates Phase 1/2 data for Duchenne candidateJune 5, 2025 | msn.comEarly Wins: RegenXBio's Gene Therapy Helps Duchenne Patients Walk Stronger, LongerJune 5, 2025 | benzinga.comREGENXBIO REPORTS NEW POSITIVE FUNCTIONAL DATA FROM PHASE I/II AFFINITY DUCHENNE® TRIAL OF RGX-202June 5, 2025 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 5, 2025 | marketbeat.comREGENXBIO (NASDAQ:RGNX) Shares Up 13.5% - Still a Buy?June 3, 2025 | marketbeat.comShort Interest in REGENXBIO Inc. (NASDAQ:RGNX) Expands By 21.9%June 3, 2025 | marketbeat.comBank of America Corp DE Reduces Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)June 3, 2025 | marketbeat.comREGENXBIO to Host Webcast Discussing Interim Functional Data from the Phase I/II AFFINITY DUCHENNE® Trial of RGX-202June 2, 2025 | prnewswire.comTwo Sigma Advisers LP Acquires 112,000 Shares of REGENXBIO Inc. (NASDAQ:RGNX)June 1, 2025 | marketbeat.comTwo Sigma Investments LP Acquires 263,495 Shares of REGENXBIO Inc. (NASDAQ:RGNX)June 1, 2025 | marketbeat.comFY2026 EPS Estimates for REGENXBIO Increased by AnalystMay 31, 2025 | marketbeat.comMillennium Management LLC Buys 1,061,187 Shares of REGENXBIO Inc. (NASDAQ:RGNX)May 26, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires 75,652 Shares of REGENXBIO Inc. (NASDAQ:RGNX)May 25, 2025 | marketbeat.comQ2 Earnings Forecast for REGENXBIO Issued By Leerink PartnrsMay 24, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Purchased by Jane Street Group LLCMay 23, 2025 | marketbeat.comRegenxbio at RBC Conference: Strategic Moves and Clinical ProgressMay 22, 2025 | investing.comREGENXBIO FY2025 EPS Forecast Reduced by Chardan CapitalMay 21, 2025 | marketbeat.comREGENXBIO Inc.: REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 MillionMay 20, 2025 | finanznachrichten.deREGENXBIO announces royalty monetization agreement for up to $250MMay 20, 2025 | msn.com Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address RGNX Media Mentions By Week RGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼-0.310.47▲Average Medical News Sentiment RGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼184▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADPT News SRPT News EWTX News BHVN News SDGR News DYN News EVO News JANX News TVTX News ANIP News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 8/11/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share REGENXBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access